Civic Intelligence

Biostrategy Partners Inc.

990 • Fiscal year 2017 • EIN 86-1104679

Jul 01, 2016 to Jun 30, 2017 • Filed on May 11, 2018

Organization ProfileWWW.BIOSTRATEGYPARTNERS.ORG
PO Box 187Montgomeryville, PA 18936-0187

(215) 393-3144

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

94th percentile

0.90x

Higher debt load relative to assets than 94% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Liabilities / Revenue

94th percentile

0.75x

Higher debt load relative to revenue than 94% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Net Margin

28th percentile

-6.4%

Higher net margin than 28% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Top Officer Pay

76th percentile

$0

Higher top officer pay than 76% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Asset Growth

94th percentile

156%

Faster asset growth than 94% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Annualized from 2016 to 2017

Revenue Growth

97th percentile

290%

Faster revenue growth than 97% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Annualized from 2016 to 2017

Balance Sheet
Liabilities / Assets94th percentile

Assets

Up

$286,226

Up $174,405 (+156%) from 2016

Net Assets

Down

$27,544

Down $21,867 (-44%) from 2016

Liabilities

Up

$258,682

Up $196,272 (+314%) from 2016

Revenue And Expenses
Liabilities / Revenue94th percentileNet Margin28th percentile

Revenue

Up

$344,076

Up $255,949 (+290%) from 2016

Expenses

Up

$365,943

Up $255,673 (+232%) from 2016

Net Income

Up

-$21,867

Up $276 (+1.2%) from 2016

Historical Trend

Balance Sheet Trend

Asset Growth94th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$400K$300K$200K$100K$0Assets 2011: $360,071Liabilities 2011: $56,505Net Assets 2011: $303,5662011Assets 2012: $237,968Liabilities 2012: $15,181Net Assets 2012: $222,7872012Assets 2013: $137,390Liabilities 2013: $12,601Net Assets 2013: $124,7892013Assets 2014: $166,794Liabilities 2014: $31,684Net Assets 2014: $135,1102014Assets 2015: $81,415Liabilities 2015: $9,861Net Assets 2015: $71,5542015Assets 2016: $111,821Liabilities 2016: $62,410Net Assets 2016: $49,4112016Assets 2017: $286,226Liabilities 2017: $258,682Net Assets 2017: $27,5442017Assets 2018: $180,876Liabilities 2018: $129,834Net Assets 2018: $51,0422018Assets 2019: $97,261Liabilities 2019: $15,994Net Assets 2019: $81,2672019Assets 2020: $124,500Liabilities 2020: $3,875Net Assets 2020: $120,6252020Assets 2021: $188,435Liabilities 2021: $60,000Net Assets 2021: $128,4352021Assets 2022: $211,417Liabilities 2022: $45,000Net Assets 2022: $166,4172022Assets 2023: $247,869Liabilities 2023: $47,2802023Assets 2024: $269,019Liabilities 2024: $76,263Net Assets 2024: $192,7562024

Highlighted filing

2017

Assets$286,226
Liabilities$258,682
Net Assets$27,544
Open 2017 Filing

Operations Trend

Revenue Growth97th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$600K$400K$200K$0-$200KExpenses 2011: $519,1832011Expenses 2012: $289,4732012Expenses 2013: $270,3642013Revenue 2014: $397,961Expenses 2014: $387,640Net Income 2014: $10,3212014Revenue 2015: $106,733Expenses 2015: $170,289Net Income 2015: -$63,5562015Revenue 2016: $88,127Expenses 2016: $110,270Net Income 2016: -$22,1432016Revenue 2017: $344,076Expenses 2017: $365,943Net Income 2017: -$21,8672017Revenue 2018: $102,526Expenses 2018: $94,448Net Income 2018: $8,0782018Revenue 2019: $178,155Expenses 2019: $147,930Net Income 2019: $30,2252019Revenue 2020: $67,507Expenses 2020: $28,149Net Income 2020: $39,3582020Revenue 2021: $119,004Expenses 2021: $111,194Net Income 2021: $7,8102021Revenue 2022: $75,003Expenses 2022: $37,021Net Income 2022: $37,9822022Revenue 2023: $82,116Expenses 2023: $47,944Net Income 2023: $34,1722023Revenue 2024: $137,399Expenses 2024: $145,232Net Income 2024: -$7,8332024

Highlighted filing

2017

Revenue$344,076
Expenses$365,943
Net Income-$21,867
Open 2017 Filing
Jump To
Filing Snapshot
Filing Period
Jul 1, 2016 to Jun 30, 2017
Signed
May 11, 2018
Return Version
2016v3.0
Gross Receipts
$344,076
Mission and Program Overview

Mission

Engaging in and supporting the development of the life sciences industry by providing scientific, business and other support services to early-stage and emerging life sciences companies and advancing technology commercialization, including providing technology development resources and establishing and supporting companies formed to commercialize technologies generated by research institutions, and more efficiently and effectively collaborating with biotechnology, diagnostic, medical device, and other companies.

Engaging in and supporting the development of the life sciences industry by providing scientific, business and other support services to early-stage and emerging life sciences companies; and advancing technology commercialization, including providing technology development resources and establishing and supporting companies formed to commercialize technologies generated by member research institutions, and more efficiently and effectively collaborating with biotechnology, diagnostic, medical device, and other companies.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$27,575$162,589▲ $135,014
Cash and Non-Interest-Bearing Accounts$13,141$110,765▲ $97,624
Pledges and Grants Receivable$43,125--
Accounts Receivable$25,000$10,000▼ $15,000
Prepaid Expenses and Deferred Charges$2,809$2,829▲ $20
Land, Buildings, and Equipment, Net$171$43▼ $128
Total Assets$111,821$286,226▲ $174,405
Liabilities
Accounts Payable and Accrued Expenses$62,410$258,682▲ $196,272
Total Liabilities$62,410$258,682▲ $196,272
Net Assets / Fund Balance
Temporarily Rstr Net Assets$113,904$14,625▼ $99,279
Unrestricted Net Assets$-64,493$12,919▲ $77,412
Total Net Assets Fund Balance$49,411$27,544▼ $21,867
Total Liabilities and Net Assets / Fund Balance$111,821$286,226▲ $174,405

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$43$3,626$3,669
Compensation and Service Providers
Top Officer Pay76th percentile

Board Members and Trustees

NameTitle
Stephen G NappiPresident
Timothy J Pelura PhdVice-president/treasurer
Kenneth S Kilgore Phd MbaBoard Observer
Lori Gavrin PhdBoard Observer
Erika SwiftDirector
Heather Rose Phd JdDirector
Heather Steinman Phd MbaDirector
Zev SunleafDirector
Revenue and Support

Revenue Composition

Contributions and Grants
$15,000
Program Service Revenue
$329,063
Investment Income
$13
Other Revenue
$0
All Other Contributions
$15,000
Change in Net Assets
$-21,867
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$245,235
Other Expenses$120,708
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$245,235--$245,235
Fees for Services Other$60,887$90-$60,977
Fees for Services Legal$19,030$10,410-$29,440
Fees for Services Management$7,499$4,103-$11,602
Fees for Services Accounting$7,027$3,843-$10,870
Insurance$4,026$2,203-$6,229
Office Expenses-$377-$377
Advertising-$208-$208
Depreciation Depletion-$128-$128
Travel-$63-$63
Other Expenses$10$4-$14
Total Functional Expenses$344,514$21,429$0$365,943
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Pennsylvania State UniversityState College, PA501(c)3(1) Enveloped Virus-like Particles as Vehicles for Delivery of Protein and Peptides.(2) Integrating Genetic and Epiomics Data to Identify Functional Causal Variance in Complex Disease.$60,000
Temple University Research ServicesPhiladelphia, PA501(c)3(1)development of a Bacteriophage Targeting Enteropathogenic E.coli(2) Novel Mechanisms in Control of T-cell Activation for Anti-cancer Immunity.$60,000
Lankenau Institute for Medical ResearchWynnewood, PA501(c)3Characterization of a Humanized B/t Cell Penetrating Rhob Antibody to Treat Rheumatoid Arthritis.$30,000
Penn State University Center for Medical InnovationHershey, PA501(c)3Purpose Stem Cell Derived Auto Ag-specific Tregs for Therapeutic Use in Rheumatoid Arthritis.$30,000
University of Arizona Sponsored Projects ServicesTucson, AZ501(c)3Related to the Use of Muc1 Mimetic to Control Pulmonary Inflammation.$30,000
Wistar InstitutePhiladelphia, PA501(c)3Identification of Potential New Tumor Antigen$15,000
Wistar InstitutePhiladelphia, PA501(c)3Enhancing Tumor Infiltrating Lymphocyte Function$15,000
University of ArizonaTucson, AZ501(c)3Use of Mu01 to Control Pulmonary Inflammation$5,235
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“The finance committee first reviews the 990 and makes a recommendation to take to the board of directors. The board of directors review it either in a regularly scheduled board of directors meeting or the return is sent via email along with a form to send back documenting each director's review of the 990, all of which must be collected prior to filing.”

Form 990, Part VI, Section B, Line 12C

“Interested persons as defined in the conflict of interest policy have a duty to disclose potential conflicts of interest to the bod, which then determines whether there is a conflict and what course of action to take.”

Form 990, Part VI, Section B, Line 15A

“If compensation is paid, the board of directors chair selects a member of the executive committee (ec) to collect data related to the compensation provided by biosp to its employees and key compensated contractors. The member of the ec will provide a summary of the findings to the chair and the ec. The ec will discuss the data and have the minutes reflect the discussion and vote on an appropriate compensation for the individual(s) whose package is under review.”

Form 990, Part VI, Section C, Line 19

“Biostrategy partners, inc. Makes its governing documents, conflict of interest policy, and financial statements available to the public upon request.”

Filing and Contact Details

Filer

Filer Name
Biostrategy Partners Inc
EIN
86-1104679
Phone
2153933144
Address
PO BOX 187, MONTGOMERYVILLE, PA 18936-0187

Signing Officer

Name
Stephen G Nappi
Title
President
Phone
2153933144
Signed
2018-05-11
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Stephen G Nappi
Formed
2004
Legal Domicile
Pa
Voting Board Members
8
Independent Board Members
8
Employees
0
Volunteers
8

Preparer

Firm
Kreischer Miller
Address
100 WITMER ROAD SUITE 350, HORSHAM, PA 19044-2369
Preparer
Christopher M Pekula
Phone
2154414600
Supplemental Narrative

Additional Explanations

Form 990, Part IX, Line 11G

“Consultation: program service expenses 60,887. Management and general expenses 90. Fundraising expenses 0. Total expenses 60,977.”

Raw XML AppendixShowing 400 of 468 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt062410
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0258682
IRS990/AccountsReceivableGrp/BOYAmt025000
IRS990/AccountsReceivableGrp/EOYAmt010000
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0ENGAGING IN AND SUPPORTING THE DEVELOPMENT OF THE LIFE SCIENCES INDUSTRY BY PROVIDING SCIENTIFIC, BUSINESS AND OTHER SUPPORT SERVICES TO EARLY-STAGE AND EMERGING LIFE SCIENCES COMPANIES; AND ADVANCING TECHNOLOGY COMMERCIALIZATION, INCLUDING PROVIDING TECHNOLOGY DEVELOPMENT RESOURCES AND ESTABLISHING AND SUPPORTING COMPANIES FORMED TO COMMERCIALIZE TECHNOLOGIES GENERATED BY MEMBER RESEARCH INSTITUTIONS, AND MORE EFFICIENTLY AND EFFECTIVELY COLLABORATING WITH BIOTECHNOLOGY, DIAGNOSTIC, MEDICAL DEVICE, AND OTHER COMPANIES.
IRS990/AdvertisingGrp/ManagementAndGeneralAmt0208
IRS990/AdvertisingGrp/TotalAmt0208
IRS990/AllOtherContributionsAmt015000
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0BRENDA GLASER ABRAMS ESQ COUNSEL
IRS990/BooksInCareOfDetail/PhoneNum06106680019
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0LUNDBELDECOSMILBY PC450 N NARBERTH
IRS990/BooksInCareOfDetail/USAddress/CityNm0NARBERTH
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd019072
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt013141
IRS990/CashNonInterestBearingGrp/EOYAmt0110765
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt015000
IRS990/CYGrantsAndSimilarPaidAmt0245235
IRS990/CYInvestmentIncomeAmt013
IRS990/CYOtherExpensesAmt0120708
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt0329063
IRS990/CYRevenuesLessExpensesAmt0-21867
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0365943
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0344076
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt0128
IRS990/DepreciationDepletionGrp/TotalAmt0128
IRS990/Desc0PHARMA GERMINATOR, A PROGRAM DESIGNED TO FACILITATE INDUSTRY-ACADEMIC COLLABORATIONS THROUGH A CUSTOMIZED SPONSORED RESEARCH PROCESS, EXPANDED TO INCLUDE ADDITIONAL CORPORATE PARTNERS AND RESEARCH INSTITUTIONS. IN ADDITION TO THE LONG-STANDING PARTNERSHIP WITH JANSSEN RESEARCH & DEVELOPMENT, BIOSTRATEGY PARTNERS ENTERED INTO CONTRACTS WITH DEPUY SYNTHES AND GLAXOSMITHKILINE. THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY AND THE UNIVERSITY OF THE SCIENCES JOINED AS NEW MEMBERS OF BIOSTRATEGY PARTNERS. THESE NEW INSTITUTIONS EXPAND THE NUMBER OF RESEARCH INSTITUTIONS TO SIX, JOINING THE LANKENAU INSTITUTE OF MEDICAL RESEARCH, PENNSYLVANIA STATE UNIVERSITY, TEMPLE UNIVERSITY, THOMAS JEFFERSON UNIVERSITY, AND THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY. BASED ON THE NEW CORPORATE CONTRACTS AND EXPANDED MEMBERSHIP, BIOSTRATEGY PARTNERS LAUNCHED NEW PHARMA GERMINATOR GRANT ROUNDS IN THIS FISCAL YEAR WITH THE POTENTIAL TO FUND UP TO 13 TECHNOLOGY ADVANCEMENT PROJECTS IN THE NEXT FISCAL YEAR.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd00
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0335589
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt03843
IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt07027
IRS990/FeesForServicesAccountingGrp/TotalAmt010870
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt010410
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt019030
IRS990/FeesForServicesLegalGrp/TotalAmt029440
IRS990/FeesForServicesManagementGrp/ManagementAndGeneralAmt04103
IRS990/FeesForServicesManagementGrp/ProgramServicesAmt07499
IRS990/FeesForServicesManagementGrp/TotalAmt011602
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt090
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt060887
IRS990/FeesForServicesOtherGrp/TotalAmt060977
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/PersonNm0TIMOTHY J PELURA PHD
IRS990/Form990PartVIISectionAGrp/PersonNm1STEPHEN G NAPPI
IRS990/Form990PartVIISectionAGrp/PersonNm2HEATHER ROSE PHD JD
IRS990/Form990PartVIISectionAGrp/PersonNm3HEATHER STEINMAN PHD MBA
IRS990/Form990PartVIISectionAGrp/PersonNm4ZEV SUNLEAF
IRS990/Form990PartVIISectionAGrp/PersonNm5ERIKA SWIFT
IRS990/Form990PartVIISectionAGrp/PersonNm6LORI GAVRIN PHD
IRS990/Form990PartVIISectionAGrp/PersonNm7KENNETH S KILGORE PHD MBA
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/TitleTxt0VICE-PRESIDENT/TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt1PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6BOARD OBSERVER
IRS990/Form990PartVIISectionAGrp/TitleTxt7BOARD OBSERVER
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02004
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt08
IRS990/GrantAmt0245235
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0245235
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0245235
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt0344076
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt08
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InsuranceGrp/ManagementAndGeneralAmt02203
IRS990/InsuranceGrp/ProgramServicesAmt04026
IRS990/InsuranceGrp/TotalAmt06229
IRS990/InvestmentIncomeGrp/ExclusionAmt013
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt013
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt05
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt03626
IRS990/LandBldgEquipBasisNetGrp/BOYAmt0171
IRS990/LandBldgEquipBasisNetGrp/EOYAmt043
IRS990/LandBldgEquipCostOrOtherBssAmt03669
IRS990/LegalDomicileStateCd0PA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0BIOSTRATEGY PARTNERS, INC. (BIOSP) IS A 501C3 NONPROFIT CONSORTIUM OF ACADEMIC MEDICAL CENTERS AND RESEARCH INSTITUTES COMMITTED TO THE DEVELOPMENT AND TRANSFER OF ACADEMIC RESEARCH INTO THE MARKETPLACE. BIOSP DEVELOPS AND OFFERS PROGRAMS AND SERVICES TO FOSTER INDUSTRY-ACADEMIC COLLABORATION, AID TECHNOLOGY DEVELOPMENT AND COMMERCIALIZATION, AND CONTRIBUTE TO THE ONGOING EDUCATION OF FACULTY AND GRADUATE STUDENTS ABOUT THE COMMERCIALIZATION AND TECHNOLOGY TRANSFER PROCESSES.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt049411
IRS990/NetAssetsOrFundBalancesEOYAmt027544
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0377
IRS990/OfficeExpensesGrp/TotalAmt0377
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0PROGRAM EXPENSES
IRS990/OtherExpensesGrp/Desc1MISCELLANEOUS
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt04
IRS990/OtherExpensesGrp/ProgramServicesAmt0800
IRS990/OtherExpensesGrp/ProgramServicesAmt110
IRS990/OtherExpensesGrp/TotalAmt0800
IRS990/OtherExpensesGrp/TotalAmt114
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt043125
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt02809
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt02829
IRS990/PrincipalOfficerNm0STEPHEN G NAPPI
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0900099
IRS990/ProgramServiceRevenueGrp/BusinessCd1900099
IRS990/ProgramServiceRevenueGrp/BusinessCd2900099
IRS990/ProgramServiceRevenueGrp/Desc0CONTRACT INCOME
IRS990/ProgramServiceRevenueGrp/Desc1CONSORTIUM MEMBERSHIP
IRS990/ProgramServiceRevenueGrp/Desc2GOVERNMENT SERVICE GRA
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0240000
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt155000
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt234063
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0240000
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt155000
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt234063
IRS990/ProgSrvcAccomActy2Grp/Desc0BIOSTRATEGY PARTNER'S PRACTICAL KNOWLEDGE SERIES (PKS) OF EDUCATIONAL EVENTS PROVIDES PRACTICAL AND TACTICAL CONTENT, DELIVERED BY EXPERTS, WITH A FOCUS ON TRANSLATIONAL SCIENCE AND THE COMMERCIALIZATION OF TECHNOLOGIES ARISING FROM MEMBER UNIVERSITIES AND RESEARCH INSTITUTIONS. PKS BROADCASTS ALL CONTENT TO THE MEMBERS OF BIOSTRATEGY PARTNERS, WHICH EXPANDED FROM FOUR INSTITUTIONS TO SIX IN THIS FISCAL YEAR.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt08925
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt00
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt044999
IRS990/PYInvestmentIncomeAmt02
IRS990/PYOtherExpensesAmt065271
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt088125
IRS990/PYRevenuesLessExpensesAmt0-22143
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt0110270
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt088127
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-21867
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RevenueAmt0329063
IRS990/SavingsAndTempCashInvstGrp/BOYAmt027575
IRS990/SavingsAndTempCashInvstGrp/EOYAmt0162589
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt015000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt05500
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt08150
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt028650
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt013
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt02
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt05
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0111
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt0219
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0350
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt01078089
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus2YearsAmt01728
IRS990ScheduleA/OtherIncome170Grp/TotalAmt01728
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.93240
IRS990ScheduleA/PublicSupportPY170Pct00.96720
IRS990ScheduleA/PublicSupportTotal170Amt028650
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt015000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt05500
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt08150
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt028650
IRS990ScheduleA/TotalSupportAmt030728
IRS990/ScheduleBRequiredInd00
IRS990ScheduleD/EquipmentGrp/BookValueAmt043
IRS990ScheduleD/EquipmentGrp/DepreciationAmt03626
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt03669
IRS990ScheduleD/TotalBookValueLandBuildingsAmt043
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt015000
IRS990ScheduleI/RecipientTable/CashGrantAmt115000
IRS990ScheduleI/RecipientTable/CashGrantAmt25235
IRS990ScheduleI/RecipientTable/CashGrantAmt330000
IRS990ScheduleI/RecipientTable/CashGrantAmt460000
IRS990ScheduleI/RecipientTable/CashGrantAmt560000
IRS990ScheduleI/RecipientTable/CashGrantAmt630000
IRS990ScheduleI/RecipientTable/CashGrantAmt730000
IRS990ScheduleI/RecipientTable/IRCSectionDesc0501(C)3
IRS990ScheduleI/RecipientTable/IRCSectionDesc1501(C)3
IRS990ScheduleI/RecipientTable/IRCSectionDesc2501(C)3
IRS990ScheduleI/RecipientTable/IRCSectionDesc3501(C)3
IRS990ScheduleI/RecipientTable/IRCSectionDesc4501(C)3
IRS990ScheduleI/RecipientTable/IRCSectionDesc5501(C)3
IRS990ScheduleI/RecipientTable/IRCSectionDesc6501(C)3
IRS990ScheduleI/RecipientTable/IRCSectionDesc7501(C)3
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0IDENTIFICATION OF POTENTIAL NEW TUMOR ANTIGEN
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1ENHANCING TUMOR INFILTRATING LYMPHOCYTE FUNCTION
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt2USE OF MU01 TO CONTROL PULMONARY INFLAMMATION
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt3CHARACTERIZATION OF A HUMANIZED B/T CELL PENETRATING RHOB ANTIBODY TO TREAT RHEUMATOID ARTHRITIS.
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt4(1)DEVELOPMENT OF A BACTERIOPHAGE TARGETING ENTEROPATHOGENIC E.COLI(2) NOVEL MECHANISMS IN CONTROL OF T-CELL ACTIVATION FOR ANTI-CANCER IMMUNITY.
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt5(1) ENVELOPED VIRUS-LIKE PARTICLES AS VEHICLES FOR DELIVERY OF PROTEIN AND PEPTIDES.(2) INTEGRATING GENETIC AND EPIOMICS DATA TO IDENTIFY FUNCTIONAL CAUSAL VARIANCE IN COMPLEX DISEASE.
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt6PURPOSE STEM CELL DERIVED AUTO AG-SPECIFIC TREGS FOR THERAPEUTIC USE IN RHEUMATOID ARTHRITIS.
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt7RELATED TO THE USE OF MUC1 MIMETIC TO CONTROL PULMONARY INFLAMMATION.
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0WISTAR INSTITUTE
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1WISTAR INSTITUTE
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt2UNIVERSITY OF ARIZONA
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt3LANKENAU INSTITUTE FOR MEDICAL RESEARCH
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt4TEMPLE UNIVERSITY RESEARCH SERVICES
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt5PENNSYLVANIA STATE UNIVERSITY
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt6PENN STATE UNIVERSITY CENTER FOR MEDICAL INNOVATION
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt7UNIVERSITY OF ARIZONA SPONSORED PROJECTS SERVICES
IRS990ScheduleI/RecipientTable/RecipientEIN0236434390
IRS990ScheduleI/RecipientTable/RecipientEIN1236434390
IRS990ScheduleI/RecipientTable/RecipientEIN2742652689
IRS990ScheduleI/RecipientTable/RecipientEIN3232175659
IRS990ScheduleI/RecipientTable/RecipientEIN4231365971
IRS990ScheduleI/RecipientTable/RecipientEIN5246000376
IRS990ScheduleI/RecipientTable/RecipientEIN6251854772
IRS990ScheduleI/RecipientTable/RecipientEIN7742652689
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt03601 SPRUCE STREET
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt13601 SPRUCE STREET
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt2220 WEST 6TH STREET
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt3100 EAST LANCASTER AVENUE
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt41101 WEST MONTGOMERY AVENUE
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt5227 WEST BEAVER AVENUE
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt6500 UNIVERSITY DRIVE
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt71303 EAST UNIVERSITY BLVD
IRS990ScheduleI/RecipientTable/USAddress/CityNm0PHILADELPHIA
IRS990ScheduleI/RecipientTable/USAddress/CityNm1PHILADELPHIA
IRS990ScheduleI/RecipientTable/USAddress/CityNm2TUCSON
IRS990ScheduleI/RecipientTable/USAddress/CityNm3WYNNEWOOD
IRS990ScheduleI/RecipientTable/USAddress/CityNm4PHILADELPHIA
IRS990ScheduleI/RecipientTable/USAddress/CityNm5STATE COLLEGE
IRS990ScheduleI/RecipientTable/USAddress/CityNm6HERSHEY
IRS990ScheduleI/RecipientTable/USAddress/CityNm7TUCSON
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0PA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd1PA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd2AZ
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd3PA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd4PA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd5PA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd6PA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd7AZ
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd019104
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd119104
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd285701
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd319096
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd419122
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd516801
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd617033
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd785719
IRS990ScheduleI/RecipientTable/ValuationMethodUsedDesc0FMV / CASH
IRS990ScheduleI/RecipientTable/ValuationMethodUsedDesc1FMV / CASH
IRS990ScheduleI/RecipientTable/ValuationMethodUsedDesc2FMV / CASH
IRS990ScheduleI/RecipientTable/ValuationMethodUsedDesc3FMV / CASH
IRS990ScheduleI/RecipientTable/ValuationMethodUsedDesc4FMV / CASH
IRS990ScheduleI/RecipientTable/ValuationMethodUsedDesc5FMV / CASH
IRS990ScheduleI/RecipientTable/ValuationMethodUsedDesc6FMV / CASH
IRS990ScheduleI/RecipientTable/ValuationMethodUsedDesc7FMV / CASH
IRS990ScheduleI/SupplementalInformationDetail/ExplanationTxt0PRIOR TO RELEASING THE FIRST TRANCHE OF FUNDING, WE REQUIRE AN APPROVED ROAD MAP DETAILING RESEARCH TO BE PERFORMED AND HOW FUNDS WILL BE SPENT. WE REQUIRE MONTHLY DOCUMENTATION OF PROGRESS AND HOLD MONTHLY UPDATE PHONE CALLS, AND A SITE VISIT. PRIOR TO RELEASING THE FINAL TRANCHE OF FUNDING, WE REQUIRE A FINAL REPORT OF SCIENTIFIC PROGRESS AGAINST MILESTONES, AS WELL AS A FINAL FINANCIAL REPORT OF HOW FUNDS WERE SPENT.
IRS990ScheduleI/SupplementalInformationDetail/FormAndLineReferenceDesc0PART I, LINE 2:
IRS990ScheduleI/Total501c3OrgCnt08
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE FINANCE COMMITTEE FIRST REVIEWS THE 990 AND MAKES A RECOMMENDATION TO TAKE TO THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS REVIEW IT EITHER IN A REGULARLY SCHEDULED BOARD OF DIRECTORS MEETING OR THE RETURN IS SENT VIA EMAIL ALONG WITH A FORM TO SEND BACK DOCUMENTING EACH DIRECTOR'S REVIEW OF THE 990, ALL OF WHICH MUST BE COLLECTED PRIOR TO FILING.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1INTERESTED PERSONS AS DEFINED IN THE CONFLICT OF INTEREST POLICY HAVE A DUTY TO DISCLOSE POTENTIAL CONFLICTS OF INTEREST TO THE BOD, WHICH THEN DETERMINES WHETHER THERE IS A CONFLICT AND WHAT COURSE OF ACTION TO TAKE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2IF COMPENSATION IS PAID, THE BOARD OF DIRECTORS CHAIR SELECTS A MEMBER OF THE EXECUTIVE COMMITTEE (EC) TO COLLECT DATA RELATED TO THE COMPENSATION PROVIDED BY BIOSP TO ITS EMPLOYEES AND KEY COMPENSATED CONTRACTORS. THE MEMBER OF THE EC WILL PROVIDE A SUMMARY OF THE FINDINGS TO THE CHAIR AND THE EC. THE EC WILL DISCUSS THE DATA AND HAVE THE MINUTES REFLECT THE DISCUSSION AND VOTE ON AN APPROPRIATE COMPENSATION FOR THE INDIVIDUAL(S) WHOSE PACKAGE IS UNDER REVIEW.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3BIOSTRATEGY PARTNERS, INC. MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4CONSULTATION: PROGRAM SERVICE EXPENSES 60,887. MANAGEMENT AND GENERAL EXPENSES 90. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 60,977.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PART VI, SECTION B, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART VI, SECTION B, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PART VI, SECTION B, LINE 15A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PART VI, SECTION C, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART IX, LINE 11G
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/StatesWhereCopyOfReturnIsFldCd0PA
IRS990/SubjectToProxyTaxInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TemporarilyRstrNetAssetsGrp/BOYAmt0113904
IRS990/TemporarilyRstrNetAssetsGrp/EOYAmt014625
IRS990/TempOrPermanentEndowmentsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt0111821
IRS990/TotalAssetsEOYAmt0286226
IRS990/TotalAssetsGrp/BOYAmt0111821
IRS990/TotalAssetsGrp/EOYAmt0286226
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt015000
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt021429
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0344514
IRS990/TotalFunctionalExpensesGrp/TotalAmt0365943
IRS990/TotalGrossUBIAmt00

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2017 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$286,226
Liabilities
$258,682
Net assets
$27,544
Revenue
$344,076
Expenses
$365,943
Net income
-$21,867
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$2.69$0.76$1.93$1.37$1.45$0.08
2023Summary only. Only limited summary data is available for this year.$2.48$0.47$0.82$0.48$0.34
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$2.11$0.45$1.66$0.75$0.37$0.38
2021Detailed filing. Detailed filing data is available for this year.$1.88$0.60$1.28$1.19$1.11$0.08
2020Detailed filing. Detailed filing data is available for this year.$1.25$0.04$1.21$0.68$0.28$0.39
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.97$0.16$0.81$1.78$1.48$0.30
2018Summary only. Only limited summary data is available for this year.$1.81$1.30$0.51$1.03$0.94$0.08
2017Detailed filing. Detailed filing data is available for this year.$2.86$2.59$0.28$3.44$3.66$0.22
2016Detailed filing. Detailed filing data is available for this year.$1.12$0.62$0.49$0.88$1.10$0.22
2015Detailed filing. Detailed filing data is available for this year.$0.81$0.10$0.72$1.07$1.70$0.64
2014Detailed filing. Detailed filing data is available for this year.$1.67$0.32$1.35$3.98$3.88$0.10
2013Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.37$0.13$1.25$2.70
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$2.38$0.15$2.23$2.89
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.60$0.57$3.04$5.19